Kedudukan dalam Saham
#1744
WuXi XDC Cayman Inc. operates as an investment holding company and a global... WuXi XDC Cayman Inc. operates as an investment holding company and a global contract research, development, and manufacturing organization (CRDMO), with operations spanning China, North America, Europe, and other international regions. The company's expertise covers the entire lifecycle, from discovery and research to development and manufacturing, of biopharmaceutical products. Specifically, it focuses on antibody-drug conjugates (ADCs), various bioconjugates, monoclonal antibody intermediates, and the crucial payload-linkers integral to bioconjugate synthesis. Founded in 2013 and headquartered in Wuxi, China, WuXi XDC Cayman Inc. is a subsidiary of WuXi Biologics (Cayman) Inc.
Perubahan (1 hari)
14.83%
Perubahan (1 tahun)
38.35%
Perdagangan WuXi XDC Cayman Inc (2268)
Harga 2268 dengan permodalan pasaran b
Modal pasaran bagi WuXi XDC Cayman Inc(2268)
Modal Pasaran: $12.98B
Sehingga August 2026, WuXi XDC Cayman Inc mempunyai modal pasaran sebanyak $12.98B. Ini menjadikan WuXi XDC Cayman Inc syarikat ke-1744th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran WuXi XDC Cayman Inc dari 2023 hingga 2026
2268 berbanding dengan 5 teratas yang paling popular stocks
| Harga 2268 |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.053T
|
+38,816.76%
|
|
|
|
|
$4.564T
|
+35,052.89%
|
|
|
|
|
$4.196T
|
+32,211.89%
|
|
|
|
|
$3.629T
|
+27,849.62%
|
|
|
|
|
$2.821T
|
+21,628.13%
|
